Literature DB >> 22869551

Clarification of data for a meta-analysis: p53 codon 72 polymorphism and prostate cancer risk.

Y-Y Mi, L-J Zhu, X-M You, S Wu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22869551     DOI： 10.4238/2012.July.19.15

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN： 1676-5680


× No keyword cloud information.
  1 in total

1.  MDM2 and P53 polymorphisms contribute together to the risk and survival of prostate cancer.

Authors:  Li Xue; Xiujuan Han; Rongrong Liu; Ziming Wang; Hecheng Li; Qi Chen; Peng Zhang; Zhenlong Wang; Tie Chong
Journal:  Oncotarget       Date:  2016-05-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.